Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1121
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMr.Bhaskar Kallappa Kurangi-
dc.date.accessioned2022-02-14T07:31:19Z-
dc.date.available2022-02-14T07:31:19Z-
dc.date.issued2021-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1121-
dc.description.abstractAbstract Melanoma is one of the most aggressive type of skin cancer, with high incidence rate and mortality, throughout the world. Despite of noteworthy development in melanoma treatment, the destructive nature of the disease makes it difficult for clinicians to manage the condition. Hence, there is need remains to achieve improved therapeutic activity and overall survival time using herbal constituents, which can offer improved efficacy over existing chemotherapy, in melanoma therapy. Resveratrol (RV) and piperine (PI) are the model drugs of choice for their potential antimelanoma activity. However, their clinical application is limited due to their poor pharmacokinetic properties. Objectives The current research work aims to investigate the effect of Cubosomal nanoformulation of RV and PI against Melanoma.Hence the objectives of thestudy are: 1. To formulate, evaluate and optimize RV and PI loaded cubosomal nanoformulation. 2. To study anticancer activity of optimized cubosomal nanoformulation against Melanoma.en_US
dc.language.isoenen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectResveratrol; Piperine; cubosome; melanoma; cell uptake; pharmacodynamicen_US
dc.titleCubosome based Nanoformulation of resveratrol and piperine For targeting melanomaen_US
dc.typePhd Thesisen_US
Appears in Collections:Faculty of Pharmacy

Files in This Item:
File Description SizeFormat 
Mr.Bhaskar Kallappa Kurangi_Jan_2021_Faculty of Pharmacy.pdf11.92 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.